29 January 2015 - Deborah Wilkes
Archived
GlaxoSmithKline and Novartis have agreed to divest several OTC brands in Europe to gain approval from the European Commission for the formation of the global consumer healthcare joint venture between the two companies. A spokesperson for GlaxoSmithKline told OTCToolbox the companies were in the process of identifying buyers for the OTC brands.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.